Editor’s note: Pending an FDA decision, 23andMe no longer offers new customers access to health reports referred to in this post. Customers who received their health information prior to November 22, 2013 will still be able to see their health reports, but those who purchased after that time will only have access to ancestry information as well as access to their uninterpreted raw data. These new customers may receive health reports in the future dependent on FDA marketing authorization.
Today we’re announcing some big news. I don’t want this moment to go by without a note of gratitude to our customers and those who have been advocates for 23andMe over the years.
We have come a long way together. Because of you we pioneered the use of personal genetics. You are helping us establish a new medical era that is defined by wellness, disease prevention, and personalized care. You also helped us create a novel research platform. By leveraging online tools, social networking and crowd sourcing, and combining them with genetics, we created a platform that has set the stage to transform the way pharma companies and academics do health and wellness research.
We want to do more.
23andMe has raised more than $50 million in new financing with the goal of reaching one million customers. To help us reach our goal, we are happy to announce today, that we are dropping our price to $99.
One million customers can be the tipping point that moves medicine into the molecular era. Hundreds of you have written to us about how genetic information changed your lives and, in some cases, saved your lives. We believe genetics should be an integral part of health care and we will work hard in the coming year to help genetics become part of everyone’s health and wellness.
A community of one million individuals will also benefit the world. A genetic data resource of this magnitude has enormous potential to address unanswered questions related to the contributions of genes, the environment and your health. Understanding these factors and their interactions could lead to major improvement in diagnostics, preventive medicine and therapeutics [Collins NATURE | VOL 429 | 27 MAY 2004].
This change is not just about a new price point for personal genetic testing. It is about an ambitious plan that could transform medicine for generations to come.
If you have questions about the new pricing please go to our FAQ or email your questions to customercare@23andMe.com.